BI
EW icon

Ballast Inc’s Edwards Lifesciences EW Stock Holding History

Ballast Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,920
Closed -$226K – 108
2022
Q1 		$226K Hold
1,920
– – 0.09% 106
2021
Q4 		$248K Hold
1,920
– – 0.1% 101
2021
Q3 		$217K Buy
+1,920
New +$219K 0.09% 90

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ballast Inc's EW Position: Q2 2022 in Review

Ballast Inc sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 1,920 shares — an estimated $226K sold.

Ballast Inc first reported a position in EW in Q3 2021 and held it in 3 quarters. The position peaked at $248K in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Ballast Inc reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Ballast Inc sold 1,920 Edwards Lifesciences shares in Q2 2022, an estimated $226K.
  • Ballast Inc first reported a position in Edwards Lifesciences in Q3 2021 and held it in 3 quarters.
  • Ballast Inc's Edwards Lifesciences position peaked at $248K in Q4 2021.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Ballast Inc's 13F filing for Q2 2022, filed 14 Jul 2022.